“Companies must approach conservatively to Kim Young-ran Law”

Compliance Program managers at pharmaceutical companies got together and made a discussion about the ‘Confrontational Strategy to Kim Young-ran Law.’

CP managers poured out questions after listening to lectures of experts. Although they were not able to come up with clear solutions to it, they found a firm will to prepare for minimum standards.

The Research Council of Pharmaceutical Complia...